Cardiovascular Effects of Raloxifene Hydrochloride
Data up to Jan 2025
Total Citations Per Year
Abstract
References (107)
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 • 6,250 citations
Cloning of a novel receptor expressed in rat prostate and ovary.
1996 • 4,782 citations
Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β
1997 • 4,422 citations
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 • 3,285 citations
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 • 2,281 citations
ERβ: Identification and characterization of a novel human estrogen receptor
1996 • 2,262 citations
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
1997 • 2,244 citations
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 • 2,008 citations
Regulatory Functions of the Vascular Endothelium
1990 • 1,899 citations
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 • 1,808 citations
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 • 1,641 citations
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
1991 • 1,603 citations
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 • 1,532 citations
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
1996 • 1,323 citations
Estrogen and Coronary Heart Disease in Women
1991 • 1,237 citations
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
1990 • 1,066 citations
Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women
1994 • 708 citations
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
1998 • 702 citations
Endothelial Dysfunction: Does It Matter? Is It Reversible?
1997 • 680 citations
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
1995 • 676 citations
Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.
1995 • 665 citations
Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription
1994 • 645 citations
The vascular protective effects of estrogen
1996 • 642 citations
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
1994 • 614 citations
Estrogen modulates responses of atherosclerotic coronary arteries.
1990 • 605 citations
Nitric oxide and its role in the cardiovascular system
1995 • 598 citations
Acute vascular effects of estrogen in postmenopausal women.
1994 • 557 citations
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.
1994 • 543 citations
Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.
1994 • 540 citations
Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.
1996 • 505 citations
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.
1995 • 502 citations
Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.
1994 • 501 citations
Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
1990 • 486 citations
Estrogen Promotes Angiogenic Activity in Human Umbilical Vein Endothelial Cells In Vitro and in a Murine Model
1995 • 458 citations
Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene
1996 • 432 citations
Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.
1990 • 419 citations
Hormonal Treatment of Postmenopausal Women
1994 • 385 citations
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
1997 • 379 citations
A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
1996 • 362 citations
Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans
1995 • 358 citations
Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
1987 • 355 citations
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women
1997 • 353 citations
The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial1
2000 • 334 citations
Differential Expression of Estrogen Receptors α and β mRNA During Differentiation of Human Osteoblast SV-HFO Cells
1997 • 306 citations
Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
1996 • 285 citations
Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
1991 • 276 citations
Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens
1995 • 273 citations
Circulating Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted With 17β-Estradiol and Norethisterone Acetate
1995 • 263 citations
Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
1994 • 261 citations
Antagonism of estrogen action with a new benzothiophene derived antiestrogen
1983 • 244 citations
Endothelial Dysfunction in Atherosclerosis
1996 • 243 citations
Molecular determinants of tissue selectivity in estrogen receptor modulators
1997 • 240 citations
Antioxidant potential of specific estrogens on lipid peroxidation.
1993 • 231 citations
Expression of Estrogen Receptor-β in Human Breast Tumors
1997 • 214 citations
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
1995 • 206 citations
Randomized, Double-Blind, Placebo-Controlled Study on Effects of Raloxifene and Hormone Replacement Therapy on Plasma NO Concentrations, Endothelin-1 Levels, and Endothelium-Dependent Vasodilation in Postmenopausal Women
2001 • 183 citations
Phase II Evaluation of Lyl56758 in Metastatic Breast Cancer
1988 • 180 citations
Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys1
1998 • 176 citations
Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene
1997 • 172 citations
Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid
1996 • 172 citations
Raloxifene preserves bone strength and bone mass in ovariectomized rats.
1994 • 165 citations
Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women
1999 • 161 citations
Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function
1998 • 159 citations
Effects of raloxifene hydrochloride on the endometrium of postmenopausal women
1997 • 149 citations
The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial
2000 • 141 citations
Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed Rabbits
1997 • 135 citations
Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.
1994 • 133 citations
Raloxifene Acutely Relaxes Rabbit Coronary Arteries In Vitro by an Estrogen Receptor–Dependent and Nitric Oxide–Dependent Mechanism
1999 • 133 citations
Postmenopausal hormonal replacement decreases plasma levels of endothelin-1.
1995 • 129 citations
Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
1990 • 127 citations
Expression of Estrogen Receptor- in Human Breast Tumors
1997 • 127 citations
Estrogen Receptor Ligands Modulate Its Interaction with DNA
1997 • 123 citations
Suppression of spontaneous LH surges in estrogen-treated ovariectomized rats by microimplants of antiestrogens into the preoptic brain
1989 • 120 citations
Antioxidant potential of specific estrogens on lipid peroxidation
1993 • 111 citations
Non-steroidal antioestrogens—Receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells
1984 • 110 citations
Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles1
1998 • 94 citations
Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor
1995 • 88 citations
Alternative mechanisms of action of anti-oestrogens
1994 • 85 citations
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women
1998 • 84 citations
Effect of 17β-Estradiol on Inhibition of Platelet Aggregation In Vitro Is Mediated by an Increase in NO Synthesis
1998 • 82 citations
Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys
1998 • 80 citations
Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators
1996 • 79 citations
The Role of Endothelin in Coronary Atherosclerosis
1996 • 77 citations
Non-genomic effects of estrogens and antiestrogens
1988 • 70 citations
Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
1996 • 68 citations
Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
1996 • 59 citations
Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women
1998 • 55 citations
Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
1994 • 54 citations
Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity
1997 • 52 citations
Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo
1996 • 50 citations
Raloxifene Lowers Serum Lipoprotein(A) in Healthy Postmenopausal Women
1999 • 48 citations
Endothelial dysfunction in coronary heart disease
1996 • 46 citations
Postmenopausal hormonal replacement decreases plasma levels of endothelin-1
1995 • 46 citations
Clinical Uses of Antiestrogens
1996 • 43 citations
Brzozowski, A M. et al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389, 753-758
1997 • 43 citations
Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles
1998 • 42 citations
Disposition and metabolism of a new benzothiophene antiestrogen in rats, dogs and monkeys
1984 • 42 citations
Antiestrogenic Properties of Raloxifene
1995 • 42 citations
Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions
1994 • 41 citations
Alternate antiestrogens and approaches to the prevention of breast cancer
1995 • 35 citations
Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs
1985 • 33 citations
Inhibitory Actions of Keoxifene on Luteinizing Hormone Secretion in Pituitary Gonadotrophs*
1988 • 29 citations
Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence
1996 • 27 citations
Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women [published erratum appears in J Clin Endocrinol Metab 1997 Jan;82(1):181]
1996 • 18 citations
Effects of Raloxifene in Postmenopausal Women
1998 • 15 citations
Raloxifene, Retinoids, and Lavender: "Me Too" Tamoxifen Alternatives Under Study
1996 • 13 citations
Keoxifene (LY 156758) inhibits follicle-stimulating hormone induced differentiation of cultured rat granulosa cells
1987 • 6 citations